Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis

INTRODUCTION: Gout is the most common inflammatory arthritis in men over 40 years of age. Long-term urate-lowering therapy is considered a key strategy for effective gout management. The primary outcome measure for efficacy in clinical trials of urate-lowering therapy is serum urate levels, effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Morillon, Melanie B, Stamp, Lisa, Taylor, William, Fransen, Jaap, Dalbeth, Nicola, Singh, Jasvinder A, Christensen, Robin, Lassere, Marissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051435/
https://www.ncbi.nlm.nih.gov/pubmed/27650765
http://dx.doi.org/10.1136/bmjopen-2016-012026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051435/
https://www.ncbi.nlm.nih.gov/pubmed/27650765
http://dx.doi.org/10.1136/bmjopen-2016-012026

Ejemplares similares